Stanford Starts Kindred Healthcare (KND) at Buy
More News related to KND
- Fitch Upgrades Ventas, Inc.'s IDR & Sr. Unsecured Debt to 'BBB'; Outlook Stable
- Ventas Completes Sale of Six Underperforming Assets to Kindred Healthcare
- Kindred Healthcare Completes Acquisition of Six under-Performing Assets from Ventas, Inc.
- Wachovia Upgrades Kindred Healthcare (KND) to Market Perform; Negative Concerns Now Reflected In The Stock
- Kindred Healthcare to Present at the Jefferies 3rd Annual Healthcare Conference
Stanford Group initiates coverage on Kindred Healthcare (NYSE: KND) with a Buy rating.
Kindred Healthcare, Inc. operates as a healthcare services company in the United States.
Related Categories
New CoverageStocks Mentioned
-0.65Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
